Acadian Asset Management LLC bought a new stake in Genpact Limited (NYSE:G - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 23,676 shares of the business services provider's stock, valued at approximately $1,191,000.
A number of other institutional investors have also modified their holdings of G. Envestnet Portfolio Solutions Inc. increased its stake in Genpact by 59.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock valued at $522,000 after buying an additional 3,849 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in Genpact by 20.6% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock valued at $486,000 after buying an additional 1,651 shares during the period. GAMMA Investing LLC increased its stake in Genpact by 88.0% in the 1st quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock valued at $491,000 after buying an additional 4,561 shares during the period. 111 Capital acquired a new position in Genpact in the 4th quarter valued at $301,000. Finally, Assenagon Asset Management S.A. acquired a new position in Genpact in the 1st quarter valued at $2,396,000. 96.03% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on G. Needham & Company LLC boosted their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Wall Street Zen cut shares of Genpact from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. JPMorgan Chase & Co. dropped their price objective on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 20th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 price target on the stock. Finally, Mizuho upped their price target on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 1st. Three research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, Genpact currently has an average rating of "Hold" and a consensus price target of $52.29.
View Our Latest Report on G
Genpact Price Performance
Shares of Genpact stock traded down $0.17 on Friday, hitting $41.13. The company's stock had a trading volume of 5,115,371 shares, compared to its average volume of 1,651,319. Genpact Limited has a 52-week low of $37.82 and a 52-week high of $56.76. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. The firm has a fifty day moving average price of $44.11 and a 200-day moving average price of $45.61. The company has a market capitalization of $7.17 billion, a P/E ratio of 13.66, a price-to-earnings-growth ratio of 1.43 and a beta of 0.92.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 EPS for the quarter, topping the consensus estimate of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period in the previous year, the firm earned $0.79 EPS. The business's revenue for the quarter was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, equities research analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, September 11th will be given a $0.17 dividend. The ex-dividend date is Thursday, September 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.7%. Genpact's payout ratio is currently 22.59%.
Insider Activity
In related news, SVP Piyush Mehta sold 76,902 shares of the business's stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $42.58, for a total value of $3,274,487.16. Following the sale, the senior vice president directly owned 134,880 shares in the company, valued at $5,743,190.40. The trade was a 36.31% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Balkrishan Kalra sold 55,000 shares of the business's stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the sale, the chief executive officer owned 295,246 shares in the company, valued at $12,801,866.56. This represents a 15.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is owned by insiders.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report